Skip to content

D'HAEN PHARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

D'HAEN PHARMA

BE 0843.099.155
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€168,149
2024 · €72,524+€95,625
Equity
€439,402
2024 · €271,253+€168,149
Cash
€35,586
2024 · €17,599+€17,987
Balance sheet total
€987,565
2024 · €919,617+€67,948

Largest movements

2024 to 2025
Assets
  • Current investments +€50,000

    new in 2025: €50,000

  • Cash +€17,987

    up €17,987 (+102%), from €17,599 to €35,586

    mainly Net result for the year (+€168,149) and Tax, wage and social debts (+€16,775)

Equity and liabilities
  • Reserves +€168,149

    up €168,149 (+62.5%), from €269,253 to €437,402

  • Other debts -€69,262

    down €69,262 (-80.5%), from €86,038 to €16,776

  • Debts after one year -€44,758

    down €44,758 (-9.3%), from €480,191 to €435,432

  • Tax, wage and social debts +€16,775

    up €16,775 (+140%), from €11,954 to €28,728

Income statement
  • Financial income +€100,000

    up €100,000 (+99,999,900%), from €0 to €100,000

  • Taxes +€10,593

    up €10,593 (+36.9%), from €28,707 to €39,301

  • Financial charges -€3,141

    down €3,141 (-14.4%), from €21,884 to €18,743

  • Gross operating margin +€2,984

    up €2,984 (+2.4%), from €125,113 to €128,097

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €72,524
Gross operating margin +€2,984
Other operating charges +€93
Financial income +€100,000
Financial charges +€3,141
Taxes -€10,593
Result 2025 €168,149
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€112,247
Investment -€50,000
Financing -€44,260
Cash 2024 €17,599
Net result for the year +€168,149
Receivables within one year +€854
Deferred charges and accrued income -€816
Trade debts -€749
Tax, wage and social debts +€16,775
Other debts -€69,262
Accrued charges and deferred income -€2,704
Current investments -€50,000
Debts after one year -€44,758
Current portion of long-term debt +€498
Cash 2025 €35,586
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €919,617 €987,565 +€67,948 +7.4%
Fixed assets 21/28 €865,639 €865,639 = 0.0%
Financial fixed assets 28 €865,639 €865,639 = 0.0%
Current assets 29/58 €53,978 €121,927 +€67,948 +126%
Amounts receivable within one year 40/41 €35,157 €34,304 -€854 -2.4%
Trade receivables 40 €35,157 €34,304 -€854 -2.4%
Current investments 50/53 - €50,000 +€50,000
Cash at bank and in hand 54/58 €17,599 €35,586 +€17,987 +102%
Deferred charges and accrued income 490/1 €1,222 €2,037 +€816 +66.8%
Total equity and liabilities 10/49 €919,617 €987,565 +€67,948 +7.4%
Equity 10/15 €271,253 €439,402 +€168,149 +62.0%
Contributions 10/11 €2,000 €2,000 = 0.0%
Reserves 13 €269,253 €437,402 +€168,149 +62.5%
Distributable reserves 133 €269,253 €437,402 +€168,149 +62.5%
Amounts payable 17/49 €648,364 €548,163 -€100,200 -15.5%
Amounts payable after more than one year 17 €480,191 €435,432 -€44,758 -9.3%
Financial debts 170/4 €480,191 €435,432 -€44,758 -9.3%
Amounts payable within one year 42/48 €144,382 €91,644 -€52,737 -36.5%
Current portion of amounts payable after more than one year 42 €44,260 €44,758 +€498 +1.1%
Trade debts 44 €2,130 €1,381 -€749 -35.2%
Suppliers 440/4 €2,130 €1,381 -€749 -35.2%
Taxes, remuneration and social security 45 €11,954 €28,728 +€16,775 +140%
Taxes 450/3 €11,954 €28,728 +€16,775 +140%
Other amounts payable 47/48 €86,038 €16,776 -€69,262 -80.5%
Accrued charges and deferred income 492/3 €23,791 €21,087 -€2,704 -11.4%
Other operating charges 640/8 €1,998 €1,904 -€93 -4.7%
Gross operating margin 9900 €125,113 €128,097 +€2,984 +2.4%
Operating profit (loss) 9901 €123,115 €126,192 +€3,077 +2.5%
Financial income 75/76B €0 €100,000 +€100,000 +99,999,900%
Recurring financial income 75 €0 €100,000 +€100,000 +99,999,900%
Financial charges 65/66B €21,884 €18,743 -€3,141 -14.4%
Recurring financial charges 65 €21,884 €18,743 -€3,141 -14.4%
Profit (loss) for the period before taxes 9903 €101,232 €207,450 +€106,218 +105%
Income taxes 67/77 €28,707 €39,301 +€10,593 +36.9%
Profit (loss) for the period 9904 €72,524 €168,149 +€95,625 +132%
Profit (loss) for the period to be appropriated 9905 €72,524 €168,149 +€95,625 +132%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.